Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults Bristol Myers Squibb announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active…
Actio Biosciences Announces Initiation of KYRON Phase 1b/2 Trial of ABS-1230 for the Treatment of KCNT1-Related Epilepsy and Acceptance into FDA’s Rare Disease Evidence Principles Process Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel…
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership Phibro Animal Health Corporation announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein,…
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock Viridian Therapeutics, Inc. a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for autoimmune and…
Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB Two River, LLC and Vida Ventures both part of the Bellco Health ecosystem, acknowledged the announced acquisition of Candid…
UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage biotechnology company…
Sequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup Accelerator Sequenex announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders with innovative early-stage medtech companies for mentorship and…
Chemical Reduction Solutions LLC Expands Partnership with Simoniz USA Inc. to Exclusively Commercialize Nanobubble Technology in the Car Wash Industry Chemical Reduction Solutions LLC (“CRS”), a developer of hydrodynamic cavitation-based nanobubble technology, today announced an expanded partnership with Simoniz USA…
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG Affiliates of funds advised by SK Capital Partners, LP a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today…
ŌURA Closes the Hormonal Health Data Gap ŌURA, maker of the world’s leading smart ring, announced two new experiences designed to help women navigate the hormonal shifts that shape most of their lives: Hormonal Birth Control support and Menopause Insights.…
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS) Arrowhead Pharmaceuticals, Inc. announced that the Australian Therapeutic Goods Administration (TGA) has approved REDEMPLO® (plozasiran), a small interfering RNA (siRNA) medicine,…
Nebius Agrees to Acquire Eigen AI, Strengthening Nebius Token Factory as a Frontier Inference Platform Nebius the AI cloud company, announced an agreement to acquire Eigen AI, a leading inference and model optimization company. The acquisition will strengthen Nebius Token Factory…